Ligand validation:5VLO

DTT: 2,3-DIHYDROXY-1,4-DITHIOBUTANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VLO_DTT_A_402	31%	67%	0.168	0.838	0.57	0.7	-	-	1	0	100%	1
5VLO_DTT_B_402	16%	66%	0.186	0.752	0.57	0.75	-	-	0	0	100%	1
6AYW_DTT_B_401	11%	47%	0.198	0.715	0.62	1.42	-	-	1	0	100%	1
3RTY_DTT_B_901	100%	60%	0.027	0.994	0.9	0.63	-	-	2	0	100%	1
9JFC_DTT_I_403	100%	64%	0.03	0.995	0.31	1.06	-	-	7	0	100%	1
4QUI_DTT_A_301	99%	75%	0.057	0.989	0.67	0.32	-	-	2	0	100%	1
4PS1_DTT_C_501	98%	49%	0.059	0.983	1.09	0.9	-	-	0	0	100%	1
1KV5_DTT_A_3450	96%	64%	0.063	0.969	0.65	0.73	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.